Pain in Inflammatory Joint Diseases
Recruiting now
Conditions studied: Arthritis, Arthritis, Juvenile Idiopathic, Arthritis,Rheumatoid, Arthritis, Reactive, Arthritis, Psoriatic, Spondyloarthritis (SpA)
In brief
Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with inflammatory joint diseases, with a special focus on central sensitization and cognitive functioning as a key element in chronic pain. We will also examine the risk factors and clinical impact of these factors on pain, disease activity and treatment effects in a longitudinal study of patients with inflammatory joint disesases.
Key facts
- Study ID
- NCT06718569
- Run by
- Diakonhjemmet Hospital
- People needed
- 350
- Starts
- 2025-11-11
- Expected to finish
- 2027-11-01
- Last updated by the study team
- 2026-04-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients who initiate or switch biological or targeted synthetic DMARDs
You may not qualify if…
- None
Where it is running
- Diakonhjemmet Hospital — Oslo, Norway (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.